Influenza Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Influenza Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Therapeutics Overall Market Size
2.1 Global Influenza Therapeutics Market Size: 2022 VS 2029
2.2 Global Influenza Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Influenza Therapeutics Players in Global Market
3.2 Top Global Influenza Therapeutics Companies Ranked by Revenue
3.3 Global Influenza Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Influenza Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Influenza Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Influenza Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Influenza Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Influenza Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Vaccines
4.1.3 Drugs
4.2 By Type - Global Influenza Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Influenza Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Influenza Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Influenza Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Influenza Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Influenza Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Influenza Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Influenza Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Influenza Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Influenza Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Influenza Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Influenza Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Influenza Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Influenza Therapeutics Revenue, 2018-2029
6.3.2 US Influenza Therapeutics Market Size, 2018-2029
6.3.3 Canada Influenza Therapeutics Market Size, 2018-2029
6.3.4 Mexico Influenza Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Influenza Therapeutics Revenue, 2018-2029
6.4.2 Germany Influenza Therapeutics Market Size, 2018-2029
6.4.3 France Influenza Therapeutics Market Size, 2018-2029
6.4.4 U.K. Influenza Therapeutics Market Size, 2018-2029
6.4.5 Italy Influenza Therapeutics Market Size, 2018-2029
6.4.6 Russia Influenza Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Influenza Therapeutics Market Size, 2018-2029
6.4.8 Benelux Influenza Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Influenza Therapeutics Revenue, 2018-2029
6.5.2 China Influenza Therapeutics Market Size, 2018-2029
6.5.3 Japan Influenza Therapeutics Market Size, 2018-2029
6.5.4 South Korea Influenza Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Influenza Therapeutics Market Size, 2018-2029
6.5.6 India Influenza Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Influenza Therapeutics Revenue, 2018-2029
6.6.2 Brazil Influenza Therapeutics Market Size, 2018-2029
6.6.3 Argentina Influenza Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Influenza Therapeutics Revenue, 2018-2029
6.7.2 Turkey Influenza Therapeutics Market Size, 2018-2029
6.7.3 Israel Influenza Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Influenza Therapeutics Market Size, 2018-2029
6.7.5 UAE Influenza Therapeutics Market Size, 2018-2029
7 Influenza Therapeutics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Influenza Therapeutics Major Product Offerings
7.1.4 Abbott Laboratories Influenza Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Astrazeneca PLC
7.2.1 Astrazeneca PLC Company Summary
7.2.2 Astrazeneca PLC Business Overview
7.2.3 Astrazeneca PLC Influenza Therapeutics Major Product Offerings
7.2.4 Astrazeneca PLC Influenza Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Astrazeneca PLC Key News & Latest Developments
7.3 Biocryst Pharmaceuticals, Inc.
7.3.1 Biocryst Pharmaceuticals, Inc. Company Summary
7.3.2 Biocryst Pharmaceuticals, Inc. Business Overview
7.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Major Product Offerings
7.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Biocryst Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Chiron Corporation
7.4.1 Chiron Corporation Company Summary
7.4.2 Chiron Corporation Business Overview
7.4.3 Chiron Corporation Influenza Therapeutics Major Product Offerings
7.4.4 Chiron Corporation Influenza Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Chiron Corporation Key News & Latest Developments
7.5 CSL Limited
7.5.1 CSL Limited Company Summary
7.5.2 CSL Limited Business Overview
7.5.3 CSL Limited Influenza Therapeutics Major Product Offerings
7.5.4 CSL Limited Influenza Therapeutics Revenue in Global Market (2018-2023)
7.5.5 CSL Limited Key News & Latest Developments
7.6 Daiichi Sankyo Co., Ltd.
7.6.1 Daiichi Sankyo Co., Ltd. Company Summary
7.6.2 Daiichi Sankyo Co., Ltd. Business Overview
7.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Major Product Offerings
7.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Daiichi Sankyo Co., Ltd. Key News & Latest Developments
7.7 Glaxosmithkline PLC
7.7.1 Glaxosmithkline PLC Company Summary
7.7.2 Glaxosmithkline PLC Business Overview
7.7.3 Glaxosmithkline PLC Influenza Therapeutics Major Product Offerings
7.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Glaxosmithkline PLC Key News & Latest Developments
7.8 Mitsubishi Tanabe Pharma Corporation
7.8.1 Mitsubishi Tanabe Pharma Corporation Company Summary
7.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
7.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Mitsubishi Tanabe Pharma Corporation Key News & Latest Developments
7.9 Nanotherapeutics Inc.
7.9.1 Nanotherapeutics Inc. Company Summary
7.9.2 Nanotherapeutics Inc. Business Overview
7.9.3 Nanotherapeutics Inc. Influenza Therapeutics Major Product Offerings
7.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Nanotherapeutics Inc. Key News & Latest Developments
7.10 Protein Sciences Corporation
7.10.1 Protein Sciences Corporation Company Summary
7.10.2 Protein Sciences Corporation Business Overview
7.10.3 Protein Sciences Corporation Influenza Therapeutics Major Product Offerings
7.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Protein Sciences Corporation Key News & Latest Developments
7.11 Roche Holding AG
7.11.1 Roche Holding AG Company Summary
7.11.2 Roche Holding AG Business Overview
7.11.3 Roche Holding AG Influenza Therapeutics Major Product Offerings
7.11.4 Roche Holding AG Influenza Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Roche Holding AG Key News & Latest Developments
7.12 Sanofi SA
7.12.1 Sanofi SA Company Summary
7.12.2 Sanofi SA Business Overview
7.12.3 Sanofi SA Influenza Therapeutics Major Product Offerings
7.12.4 Sanofi SA Influenza Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Sanofi SA Key News & Latest Developments
7.13 Shionogi & Co., Ltd.
7.13.1 Shionogi & Co., Ltd. Company Summary
7.13.2 Shionogi & Co., Ltd. Business Overview
7.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Major Product Offerings
7.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Shionogi & Co., Ltd. Key News & Latest Developments
7.14 Sinovac Biotech Ltd.
7.14.1 Sinovac Biotech Ltd. Company Summary
7.14.2 Sinovac Biotech Ltd. Business Overview
7.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Major Product Offerings
7.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue in Global Market (2018-2023)
7.14.5 Sinovac Biotech Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Influenza Therapeutics Market Opportunities & Trends in Global Market
Table 2. Influenza Therapeutics Market Drivers in Global Market
Table 3. Influenza Therapeutics Market Restraints in Global Market
Table 4. Key Players of Influenza Therapeutics in Global Market
Table 5. Top Influenza Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Influenza Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Influenza Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Influenza Therapeutics Product Type
Table 9. List of Global Tier 1 Influenza Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Influenza Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Influenza Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Influenza Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Influenza Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Influenza Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Influenza Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Influenza Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Influenza Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Influenza Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Influenza Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Influenza Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Influenza Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Influenza Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Influenza Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Influenza Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Influenza Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Influenza Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Influenza Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Influenza Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Influenza Therapeutics Product Offerings
Table 32. Abbott Laboratories Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Astrazeneca PLC Company Summary
Table 35. Astrazeneca PLC Influenza Therapeutics Product Offerings
Table 36. Astrazeneca PLC Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Astrazeneca PLC Key News & Latest Developments
Table 38. Biocryst Pharmaceuticals, Inc. Company Summary
Table 39. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offerings
Table 40. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Biocryst Pharmaceuticals, Inc. Key News & Latest Developments
Table 42. Chiron Corporation Company Summary
Table 43. Chiron Corporation Influenza Therapeutics Product Offerings
Table 44. Chiron Corporation Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Chiron Corporation Key News & Latest Developments
Table 46. CSL Limited Company Summary
Table 47. CSL Limited Influenza Therapeutics Product Offerings
Table 48. CSL Limited Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. CSL Limited Key News & Latest Developments
Table 50. Daiichi Sankyo Co., Ltd. Company Summary
Table 51. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offerings
Table 52. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Daiichi Sankyo Co., Ltd. Key News & Latest Developments
Table 54. Glaxosmithkline PLC Company Summary
Table 55. Glaxosmithkline PLC Influenza Therapeutics Product Offerings
Table 56. Glaxosmithkline PLC Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Glaxosmithkline PLC Key News & Latest Developments
Table 58. Mitsubishi Tanabe Pharma Corporation Company Summary
Table 59. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offerings
Table 60. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Mitsubishi Tanabe Pharma Corporation Key News & Latest Developments
Table 62. Nanotherapeutics Inc. Company Summary
Table 63. Nanotherapeutics Inc. Influenza Therapeutics Product Offerings
Table 64. Nanotherapeutics Inc. Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Nanotherapeutics Inc. Key News & Latest Developments
Table 66. Protein Sciences Corporation Company Summary
Table 67. Protein Sciences Corporation Influenza Therapeutics Product Offerings
Table 68. Protein Sciences Corporation Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Protein Sciences Corporation Key News & Latest Developments
Table 70. Roche Holding AG Company Summary
Table 71. Roche Holding AG Influenza Therapeutics Product Offerings
Table 72. Roche Holding AG Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Holding AG Key News & Latest Developments
Table 74. Sanofi SA Company Summary
Table 75. Sanofi SA Influenza Therapeutics Product Offerings
Table 76. Sanofi SA Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi SA Key News & Latest Developments
Table 78. Shionogi & Co., Ltd. Company Summary
Table 79. Shionogi & Co., Ltd. Influenza Therapeutics Product Offerings
Table 80. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Shionogi & Co., Ltd. Key News & Latest Developments
Table 82. Sinovac Biotech Ltd. Company Summary
Table 83. Sinovac Biotech Ltd. Influenza Therapeutics Product Offerings
Table 84. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. Sinovac Biotech Ltd. Key News & Latest Developments
List of Figures
Figure 1. Influenza Therapeutics Segment by Type in 2022
Figure 2. Influenza Therapeutics Segment by Application in 2022
Figure 3. Global Influenza Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Influenza Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Influenza Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Influenza Therapeutics Revenue in 2022
Figure 8. By Type - Global Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Influenza Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Influenza Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Influenza Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Influenza Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astrazeneca PLC Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Chiron Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CSL Limited Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Glaxosmithkline PLC Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nanotherapeutics Inc. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Protein Sciences Corporation Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Holding AG Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi SA Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Shionogi & Co., Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sinovac Biotech Ltd. Influenza Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
